Stereocalpin B, a new cyclic depsipeptide from the Antarctic lichen Ramalina terebrata

Author:
Lee S., Jeong S.Y., Nguyen D.L., So J.E., Kim K.H., Kim J.H., Han S.J., Suh S.-S., Lee J.H. & Youn U.J.
Year:
2022
Journal:
Metabolites
Pages:
12: 141 [11 p.]
Url:
https://doi.org/10.3390/metabo12020141
thumb
Stereocalpin B, a new cyclic depsipeptide (1), and a new dibenzofuran derivative (3), were isolated from the Antarctic lichen, Ramalina terebrata (Ramalinaceae), along with a known cyclic depsipeptide (2). The structures of new compounds were characterized by comprehensive spectrometric analyses; high-resolution fast atom bombardment mass spectrometry (HR-FABMS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). Stereocalpin B (1) existed in a rotameric equilibrium, which was confirmed using nuclear Overhauser effect spectroscopy (NOESY)/ exchange spectroscopy (EXSY) spectrum. Absolute configurations of the amino acid units in 1 were assigned using the advanced Marfey’s method and subsequent NOESY analysis of the 5- hydroxy-2,4-dimethyl-3-oxo-decanoic acid residue confirmed the complete stereochemistry of 1. Compounds 1-3 exhibited moderate antimicrobial activities against E. coli, with the IC50 values ranging from 18‒30 μg/mL. Compound 2 exhibited cell growth inhibition against HCT116 cell lines, with the IC50 value of 20 ± 1.20 μM, and compounds 1 and 2 also showed potent anti-inflammatory activities against lipopolysaccharide (LPS)-induced RAW264.7 macrophages with the IC50 values ranging from 5‒7 μM. Keywords: Ramalina terebrata; cyclic depsipeptides; dibenzofuran; antimicrobial; cytotoxicity; antiinflammation.
Id:
34137
Submitter:
zdenek
Post_time:
Saturday, 05 February 2022 19:38